# Catapult CT awards £900K contract to Cellular Origins for robotic platform

Catapult Cell and Gene Therapy has awarded a £900,000 contract to Cellular Origins Ltd to develop a Constellation robotic platform for cell therapy manufacturing. The platform will provide incubation and bioreactor transport with modular extension capabilities.

- Type: Contract
- Announced: 2024-03-26
- Where: Stevenage, East of England, United Kingdom
- Value: $1.13M (900K GBP)
- Status: completed
- Products: Constellation robotic platform, cell therapy manufacturing automation
- Sectors: [Automation and Robotics](https://endata.com/sectors/automation-robotics.md), [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Cellular Origins](https://endata.com/companies/76510.md) (supplier)
- [Catapult Cell and Gene Therapy](https://endata.com/companies/76511.md) (customer)

## Sources

- [tenderline.uk](https://tenderline.uk/tenders/constellation-robotic-platform-for-cgct-pre-gmp-advanced-therapies-digital-amp-automation--ocds-h6vhtk-044e2d), 2024-03-28: "The Platform will deliver a version of the Constellation platform to transform cell therapy manufacturing that offers baseline functionality of incubation and bioreactor transport."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.